Related Experiment Video
Updated: Jun 3, 2026
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Part I: targeted particles for cancer immunotherapy
Samar Hamdy1, Azita Haddadi, Zahra Ghotbi
1Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2N8, Canada.
Current Drug Delivery
|April 2, 2011
Summary
Targeting tumor antigens to dendritic cells (DCs) enhances anti-tumor immunity. Nanoparticle delivery systems offer specific targeting to DCs, improving cancer vaccine efficacy and reducing side effects.
Area of Science:
- Immunology
- Nanotechnology
- Oncology
Background:
- Dendritic cells (DCs) are crucial antigen-presenting cells bridging innate and adaptive immunity.
- DCs capture antigens in the periphery and migrate to lymph nodes to initiate T cell responses.
- Targeting tumor antigens to DCs is a key strategy for effective cancer immunotherapy.
Purpose of the Study:
- To review the rationale for targeting antigens to DCs in cancer immunotherapy.
- To discuss the role of DCs in initiating antigen-specific T cell responses.
- To explore nanoparticle delivery systems for targeted antigen delivery to DCs.
Main Methods:
- Review of existing literature on DC targeting and cancer vaccines.
- Discussion of nanoparticle-based antigen delivery strategies.
- Analysis of DC-specific receptors for targeted vaccine design.
Main Results:
- Nanoparticle delivery systems efficiently target tumor antigens to DCs.
- Targeting DCs can enhance anti-tumor immune responses.
- Specific DC receptor targeting (e.g., CD11c, TLRs) improves vaccine efficacy.
Conclusions:
- Targeting DCs with nanoparticle-delivered antigens is a promising cancer immunotherapy approach.
- Strategic targeting of DC receptors can optimize vaccine-induced immune responses.
- This strategy holds potential for boosting anti-tumor immunity while minimizing side effects.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...